Patterns and predictors of antimicrobial resistance among Staphylococcus spp. from canine clinical cases presented at a veterinary academic hospital in South Africa by Qekwana, Daniel N. et al.
University of Tennessee, Knoxville 
TRACE: Tennessee Research and Creative 
Exchange 
Faculty Publications and Other Works -- 
Biomedical and Diagnostic Sciences 
Veterinary Medicine -- Faculty Publications and 
Other Works 
2017 
Patterns and predictors of antimicrobial resistance among 
Staphylococcus spp. from canine clinical cases presented at a 
veterinary academic hospital in South Africa 
Daniel N. Qekwana 
University of Pretoria, Pretoria, South Africa 
James W. Oguttu 
University of South Africa, Johannesburg, South Africa 
Fortune Sithole 
Ross University School of Veterinary Medicine, Basseterre, Saint Kitts and Nevis 
Agricola Odoi 
University of Tennessee, Knoxville, USA 
Follow this and additional works at: https://trace.tennessee.edu/utk_compmedpubs 
Recommended Citation 
Qekwana, Daniel N.; Oguttu, James W.; Sithole, Fortune; and Odoi, Agricola, "Patterns and predictors of 
antimicrobial resistance among Staphylococcus spp. from canine clinical cases presented at a veterinary 
academic hospital in South Africa" (2017). Faculty Publications and Other Works -- Biomedical and 
Diagnostic Sciences. 
https://trace.tennessee.edu/utk_compmedpubs/138 
This Article is brought to you for free and open access by the Veterinary Medicine -- Faculty Publications and Other 
Works at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Faculty 
Publications and Other Works -- Biomedical and Diagnostic Sciences by an authorized administrator of TRACE: 
Tennessee Research and Creative Exchange. For more information, please contact trace@utk.edu. 
RESEARCH ARTICLE Open Access
Patterns and predictors of antimicrobial
resistance among Staphylococcus spp. from
canine clinical cases presented at a
veterinary academic hospital in South
Africa
Daniel N. Qekwana1, James W. Oguttu2, Fortune Sithole1,3 and Agricola Odoi1,4*
Abstract
Background: Antimicrobial resistance in staphylococci, often associated with treatment failure, is increasingly
reported in veterinary medicine. The aim of this study was to investigate patterns and predictors of antimicrobial
resistance among Staphylococcus spp. isolates from canine samples submitted to the bacteriology laboratory at the
University of Pretoria academic veterinary hospital between 2007 and 2012. Retrospective data of 334
Staphylococcus isolates were used to calculate the proportion of samples resistant to 15 antimicrobial agents. The
Cochran-Armitage trend test was used to investigate temporal trends and logistic regression models were used to
investigate predictors of antimicrobial resistance in Staphylococcus aureus and Staphylococcus pseudintermedius.
Results: Results show that 98.2% (55/56) of the S. aureus isolates were resistant to at least one drug while 42.9%
were multidrug resistant. Seventy-seven percent (214/278) of the S. pseudintermedius isolates were resistant to at
least one drug and 25.9% (72/278) were multidrug resistant. Resistance to lincospectin was more common among
S. aureus (64.3%) than S. pseudintermedius (38.9%). Similarly, resistance to clindamycin was higher in S. aureus (51.8%)
than S. pseudintermedius (31.7%) isolates. There was a significant (p = 0.005) increase in S. aureus resistance to
enrofloxacin over the study period. Similarly, S. pseudintermedius exhibited significant increasing temporal trend in
resistance to trimethoprim-sulphamethoxazole (p = 0.004), clindamycin (p = 0.022) and orbifloxacin (p = 0.042).
However, there was a significant decreasing temporal trend in the proportion of isolates resistant to doxycycline
(p = 0.041), tylosin (p = 0.008), kanamycin (p = 0.017) and amoxicillin/clavulanic acid (p = 0.032).
Conclusions: High levels of multidrug resistance and the increasing levels of resistance to sulphonamides,
lincosamides and fluoroquinolones among Staphylococcus spp. isolates in this study are concerning. Future studies
will need to investigate local drivers of antimicrobial resistance to better guide control efforts to address the
problem.
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Background
Resistance of Staphylococcus spp. organisms to antimicro-
bial agents used in dogs may complicate treatments and re-
sult in increased morbidity, mortality and financial burdens
to the owners [1]. According to Werckenthin et al. [2], the
prevalence of antimicrobial drug resistance in staphylococ-
cal infections in dogs, cattle and pigs is on the rise. Prescott
et al. [3], in their study conducted in Canada, observed that
the majority of S. intermedius isolates were resistant to
enrofloxacin and gentamycin. In another study by
Hauschild and Wójcik [4] carried out in Poland, it was re-
ported that 41% and 35% of S. intermedius isolates tested
were resistant to erythromycin and clindamycin, respect-
ively. In both studies, the authors attributed the high levels
of resistance to changes in the pattern of antimicrobial use
for treatment of staphylococcal infections. Moreover,
Hauschild and Wójcik [4] as well as Pellerin et al. [5] sug-
gest that rapid introduction and the over prescription of
new antimicrobial drugs in companion animals may also be
contributing to the increased antimicrobial resistance seen
in staphylococcal organisms. Hoekstra and Paulton [6] also
reported that the type of organism, site of isolation, sex and
age of the dogs is associated with the risk of resistance.
In South Africa, 269,794 kg of parenteral antimicrobials
were sold between 2002 and 2004, with penicillins being
the most commonly (60%) sold antimicrobial followed by
tetracyclines (32%) [7]. A study by Kudakwashe [8] on anti-
microbial usage patterns among companion animal veteri-
narians in South Africa reported that the most commonly
used antimicrobials by the respondents were cephalospo-
rins (100%), followed by penicillins (98%), quinolones
(95%), and lincosamides (52%). In addition, 28% of the
respondents indicated that they did not undertake routine
antibiograms in cases of therapeutic failures. This is surpris-
ing considering 81% of the respondents indicated that
patients returned to the clinic due to treatment failures
following use of the prescribed antimicrobials [8].
Although, several studies have reported increased anti-
microbial resistance among S. intermedius isolates to
ampicillin, penicillin and tetracycline [5, 9], not much infor-
mation is available on antimicrobial resistance trends in
Staphylococcus spp. in South Africa. Moreover, no work
has been done to investigate the predictors of resistance
among Staphylococcus spp. isolates from clinical cases.
Therefore, the aim of this study was to investigate patterns
and predictors of antimicrobial resistance among Staphylo-
coccus spp. isolates from canine samples submitted to the
bacteriology laboratory at the University of Pretoria
academic veterinary hospital between 2007 and 2012.
Methods
Data collection and preparation
This was a retrospective study of Staphylococcus spp.
isolates from canine clinical samples submitted to the
University of Pretoria bacteriology laboratory as part of
the routine diagnostic evaluation of cases presented to
the university veterinary academic hospital between
January 2007 and December 2012. All samples origi-
nated from cases treated at the university hospital. The
bacteriology laboratory does not process samples from
other sites/clinics/hospitals implying that samples in-
cluded in the study are all from animals that were
treated at the academic hospital. The data were assessed
for duplicate entries, mixed infections (i.e. more than
one isolate per sample), and if any animals were sampled
multiple times during the study period. No duplicates
were identified. Moreover, there were no samples with
mixed infections (i.e. no samples with more than one
isolate). Additionally, the dataset did not contain
multiple tests from the same patient. The analyses were
performed at isolate-level. However, since each sample
had only one isolate, it implies that the results of isolate-
level analysis are the same as sample level analysis (i.e.
no problem of clustering arises).
A total of 334 confirmed Staphylococcus isolates con-
sisting of S. aureus or S. pseudintermedius isolates were
included in this study. Each case included in the analysis
had data on the following variables: site of collection,
breed, sex, age, date of submission and the antimicrobial
agents tested. The American Kennel Club (AKC) breed
classification was modified and used to classify breeds of
dogs into the following categories: working, sporting,
herding, hound, toy, terrier, nonsporting and mix-breed
(http://www.akc.org/dog-breeds/). Staphylococcus species
were identified based on the phenotypic characteristics
including colony characteristics, catalase, D-mannitol,
deoxyribonuclease (DNase) tests, and Gram-staining as
described by Quinn et al. [10].
Antimicrobial susceptibility testing
Staphylococcus isolates were subjected to antimicrobial
susceptibility testing against a panel of 15 drugs using
the disc diffusion method. The following antimicrobials
were included in the panel: 30 μg amikacin (AK), 30 μg
doxycycline (DOX30), 5 μg enrofloxacin (ENR), 10 μg
gentamicin (CN), 10 μg ampicillin (AM) 10 μg penicillin
G (P), 25 μg trimethoprim-sulphamethoxazole (co-tri-
moxazole) (SXT), 30 μg chloramphenicol (C), 30 μg
cephalothin (KF), 30 μg kanamycin (K), 2 μg clindamy-
cin (MY), 100 μg lincospectin (LS100), 5 μg orbifloxacin
(OBX5), 20/10 μg amoxicillin/clavulanic acid (AMC20/
10) and 15 μg tylosin (TY). Unfortunately, since the
laboratory does not routinely assess for methicillin sus-
ceptibility, the panel did not include this drug and there-
fore this study was not able to investigate the resistance
of Staphylococcus spp. to methicillin. The laboratory
from where the data were obtained, follows the Clinical
and Laboratory Standards Institute (CLSI) procedures
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[11–17] for isolation, testing and classification to deter-
mine the susceptibility profile (Susceptible, Intermediate
or Resistant) of Staphylococcus isolates. The original raw
data with exact diameter measurements of the inhibition
zones were not available for this retrospective study.
Thus, only interpretations of the susceptibility test re-
sults (i.e., Susceptible, Intermediate or Resistant) were
available. Therefore, although a newer version of the
CLSI document [18] is currently available it was not
possible to interpret the susceptibility profile of isolates
using this newer version of the document. For the
purposes of the study, intermediate susceptibility was
considered as susceptible and therefore re-coded as such
for all subsequent analyses.
Data analysis
All the statistical analyses were performed using SAS 9.4
(SAS Institute Inc., Cary, NC, USA) statistical package.
The data were assessed for missing data and inconsisten-
cies such as improbable values. Age was categorised into
<2 years, 2–4 years, 4–6 years, 6–8 years and >8 years.
The frequencies and proportions of all categorical vari-
ables together with their 95% confidence intervals were
calculated. Associations between categorical variables
were assessed using the Chi-square or Fishers Exact tests
where appropriate. The Cochran–Armitage trend tests
were used to assess temporal trends in the proportion of
samples resistant to each antimicrobial agent between
2007 and 2012. Statistical significance was assessed at
5% level of significance for all the above tests.
Investigation of the predictors of antimicrobial resist-
ance (resistance to at least one antimicrobial) was per-
formed in two steps. In the first step simple binary
logistic regression models were fitted with antimicrobial
resistance status (yes/no) as the outcome and each of
the suspected predictors available in the dataset (age,
sex, breed) as the explanatory variables. For each of the
simple binary logistic regression models, the predictor
variables with p-values less than 0.20 were considered
for inclusion in the multivariable logistic regression
model fit in the second step of the modeling effort. In
this second step, a multivariable logistic regression
model using manual backwards selection was fitted con-
taining all variables that had potential univariate associa-
tions (p < 0.2) with the outcome. Confounding was
assessed by comparing the change in parameter estimate
of the variables in the model with and without the sus-
pected confounding variable. If there was a 20% change
in the estimate, the variable of interest was considered
to be a significant confounder and was retained in the
final model. The odds ratios and their corresponding
95% confidence intervals were computed for all variables
included in the final model. The predictor variables with
p-values <0.05 were considered to be statistically
significant based on the Wald Chi-Squared Test. Steps 1
and 2 above were repeated with binary (yes/no) multi-
drug resistance (resistance to three or more antimicro-
bial classes) as the outcome variable. Goodness of fit of
the final models was assessed using the Hosmer-
Lemeshow goodness of fit test.
Results
Antimicrobial resistance patterns
Of the 1497 samples tested, 26.5% (396/1497) were
Staphylococcus positive and included S. aureus (n = 57),
S. epidermidis (n = 11), S. pseudintermedius (n = 284),
Staphylococcus. spp. (n = 43) and S. felis (n = 1). Seven
isolates [S. pseudintermedius (n = 6) and S. aureus
(n = 1)] were not included in subsequent analyses due to
missing information. Therefore, this study focuses only
on the 334 samples that were positive for S. pseudinter-
medius (n = 278) or S. aureus (n = 56) and that did not
have missing information. Twenty-five different types of
specimens tested positive for Staphylococcus spp. with
the skin contributing the most samples (34.4%, 115/334),
followed by ear canal (29.9%, 100/334) while the rest of
the 23 different specimen types making up the
remaining 35.6% (119/334).
Over 50% of the S. aureus isolates were resistant to
ampicillin (66.1%), penicillin (64.3%), lincospectin
(64.3%), and clindamycin (51.8%). Similarly, over 50% of
the S. pseudintermedius isolates were resistance to ampi-
cillin (57.9%) and penicillin (54.3%) (Fig. 1). In addition,
significant differences were observed in the proportion
of S. pseudintermedius and S. aureus resistance to lin-
cospectin (p = 0.0006) and clindamycin (p = 0.0055)
(Fig. 1). In both instances, the proportion of S. aureus
isolates were significantly higher than those of S. pseu-
dintermedius isolates. These results show that the level
of resistance among Staphylococcus isolates from dogs
presented at the teaching hospital was very high, and
also showed that S. aureus tended to exhibit higher
resistance levels to certain antimicrobials compared to S.
pseudintermedius.
Temporal patterns in resistance patterns of S. aureus and
S. pseudintermedius
The proportions of S. aureus isolates resistant to the
different antimicrobials is shown in Table 1. Cochran-
Armitage trend test showed that the proportion of S.
aureus isolates that were resistant to doxycycline
(p = 0.0412) or tylosin (p = 0.0083) significantly
decreased from 37.5% in 2007 to 0.0% in 2012, while the
proportion resistant to kanamycin significantly (p = 0.0167)
decreased from 26.7% in 2008 to 0.0% in 2012. Similarly, a
significant (p = 0.0317) decrease (37.5 to 0%) in the propor-
tion of S. aureus isolates resistant to amoxicillin/clavulanic
acid was observed between 2007 and 2011. However,
Qekwana et al. BMC Veterinary Research  (2017) 13:116 Page 3 of 9
increasing levels of resistance among S. aureus isolates to
amoxicillin/clavulanic acid emerged by the end of 2012. A
significant (p = 0.0052) increase in the level of resistance to
enrofloxacin among S. aureus isolates was also observed
between 2007 and 2012 (Fig. 2).
The distributions of resistance among S. pseudinterme-
dius isolates to the different antimicrobials is shown in
Table 2. Significant increases in the proportions of
resistant isolates to trimethoprim-sulphamethoxazole
(p = 0.0040), clindamycin (p = 0.0221) and orbifloxacin
(p = 0.0418) were observed among S. pseudintermedius
isolates between 2007 and 2012 (Fig. 3, Table 2). Among
S. pseudintermedius isolates, the proportion that were
resistant to clindamycin increased until 2011 (59%) but
subsequently decreased to 28% in 2012, while, the
proportion of isolates that were resistant to orbifloxacin
increased from 0 to 11% by 2012. Similarly, we observed
an increase in the proportion of isolates resistant to
Fig. 1 Proportions of S. aureus and S. pseudintermedius samples resistant to each of the 15 antimicrobials tested at the University of Pretoria
bacteriology laboratory, 2007 and 2012
Table 1 Trends in antimicrobial resistance of S. aureus from samples tested at the University of Pretoria bacteriology laboratory,
2007–2012
Group Antimicrobials Resistance to antimicrobial agents by year aP-values of
CAT Test2007 2008 2009 2010 2011 2012
β-lactams Penicillin 75.0 (6/8) 80.0 (12/15) 63.6 (7/11) 50.0 (5/10) 50.0 (3/6) 50.0 (3/6) 0.089
Ampicillin 75.0 (6/8) 80.0 (12/15) 63.6 (7/11) 60.0 (6/10) 50.0 (3/6) 50.0 (3/6) 0.124
Cephalothin 25.0 (2/8) 6.7 (1/15) 9.1 (1/11) 10.0 (1/10) 0.0 (0/6) 0.0 (0/6) 0.181
Aminoglycosides Amikacin 0.0 (0/8) 20.0 (3/15) 9.1 (1/11) 0.0 (0/10) 0.0 (0/6) 0.0 (0/6) 0.258
Gentamicin 12.5 (1/8) 20.0 (3/15) 9.1 (1/11) 0.0 (0/10) 0.0 (0/6) 0.0 (0/6) 0.098
Kanamycin 25.0 (2/8) 26.7 (4/15) 9.1 (1/11) 0.0 (0/10) 0.0 (0/6) 0.0 (0/6) 0.017
Tetracyclines Doxycycline 37.5 (3/8) 26.7 (4/15) 36.4 (4/11) 20.0 (2/10) 0.0 (0/6) 0.0 (0/6) 0.041
Fluoroquinolones Enrofloxacin 0.0 (0/8) 6.7 (1/15) 0.0 (0/11) 0.0 (0/10) 16.7 (1/6) 50.0 (3/6) 0.005
Orbifloxacin 12.5 (1/8) 20.0 (3/15) 9.1 (1/11) 0.0 (0/10) 16.7 (1/6) 33.3 (2/6) 0.718
Potentiated-sulfas Co-trimoxazoleb 37.5 (3/8) 33.3 (5/15) 27.3 (3/11) 10.0 (1/10) 0.0 (0/6) 16.7 (1/6) 0.067
Amphenicols Chloramphenicol 33.3 (1/3) 20.0 (3/15) 9.1 (1/11) 10.0 (1/10) 40.0 (2/5) 33.3 (2/6) 0.552
Macrolides Tylosin 37.5 (3/8) 33.3 (5/15) 0.0 (0/11) 10.0 (1/10) 0.0 (0/6) 0.0 (0/6) 0.008
Aminoglycoside-lincosamides Lincospectinc 37.5 (3/8) 80.0 (12/15) 54.6 (6/11) 70.0 (7/10) 50.0 (3/6) 83.3 (5/6) 0.478
Lincosamides Clindamycin 50.0 (4/8) 60.0 (9/15) 45.5 (5/11) 60.0 (6/10) 50.0 (3/6) 33.3 (2/6) 0.552
Others Amoxicillin/clavulanic acid 37.5 (3/8) 33.3 (5/15) 9.1 (1/11) 0.0 (0/10) 0.0 (0/6) 16.7 (1/6) 0.032
aP-values of CAT Test= P-value of Cochran-Armitage trend test
bCo-trimoxazole = Trimethoprim-sulphamethoxazole
cLincospectin = Espectinomycine-lincomycine
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trimethoprim-sulphamethoxazole from 2.5% in 2007 to
22% in 2012 among S. pseudintermedius isolates.
Proportions of AMR or MDR among isolates of S. aureus
and S. pseudintermedius
Of the 334 isolates, 80.5% (269/334) exhibited antimicro-
bial resistance (AMR) to at least one drug, while 28.7%
(96/334) were multidrug resistant resistant (MDR).
AMR was significantly (p = 0.0003) more common
among S. aureus (98.2%, 55/56) than S. pseudinterme-
dius (76.98%, 214/278). Similarly, MDR was also signifi-
cantly (p = 0.0105) more frequent among S. aureus
(42.9%, 24/56) than S. pseudintermedius (25.9%, 72/278).
No significant temporal trends were observed in the
proportion of AMR S. aureus (p = 0.1580) or S. pseudin-
termedius (p = 0.7312) between 2007 and 2012 (Fig. 4).
However, the proportion of AMR samples was signifi-
cantly (p = 0.0003) higher among S. aureus than S.
Fig. 2 Antimicrobial agents showing significant temporal trends in resistance based on the Cochran-Armitage trend tests among the S. aureus
isolates from canine samples tested at the University of Pretoria bacteriology laboratory, 2007–2012
Table 2 Trends in antimicrobial susceptibility of S. pseudintermedius to antimicrobial agents from samples tested at the University of
Pretoria academic veterinary laboratory, 2007–2012
Group Antimicrobial Resistance to antimicrobial agents by year aP-value of
CAT Test2007 2008 2009 2010 2011 2012
β-lactams Penicillin 37.5 (15/40) 58.6 (34/58) 50.0 (30/60) 51.2 (22/43) 73.2 (30/41) 55.6 (16/36) 0.052
Ampicillin 50.0 (20/40) 56.9 (33/58) 53.3 (32/60) 55.8 (24/43) 73.2 (30/41) 61.1 (22/36) 0.104
Cephalothin 7.5 (3/40) 5.2 (3/58) 5.0 (3/60) 2.3 (1/43) 7.3 (3/41) 2.8 (1/36) 0.555
Aminoglycosides Amikacin 0.0 (0/40) 13.8 (8/58) 3.3 (2/60) 0.0 (0/43) 4.9 (2/41) 2.8 (1/36) 0.382
Gentamicin 0.0 (0/40) 10.3 (6/53) 3.3 (2/60) 0.0 (0/43) 2.4 (1/41) 5.6 (2/36) 0.777
Kanamycin 2.5 (1/40) 3.5 (2/58) 8.3 (5/60) 4.7 (2/43) 4.9 (2/41) 5.6 (2/36) 0.612
Tetracyclines Doxycycline 12.5 (5/40) 22.4 (13/58) 15.0 (9/60) 2.3 (1/43) 17.1 (7/41) 8.3 (3/36) 0.213
Fluoroquinolones Enrofloxacin 5.0 (2/40) 5.2 (3/58) 6.7 (4/60) 4.7 (2/43) 4.9 (2/41) 16.7 (6/36) 0.122
Orbifloxacin 0.0 (0/40) 3.5 (2/58) 6.7 (4/60) 0.0 (0/43) 7.3 (3/41) 11.1 (4/36) 0.042
Potentiated sulfas Co-trimoxazoleb 2.5 (1/40) 5.2 (3/58) 20.0 (3/60) 14.0 (2/41) 17.1 (7/41) 22.2 (8/36) 0.004
Amphenicols Chloramphenicol 4.8 (1/21) 7.0 (4/57) 5.0 (3/60) 4.9 (2/41) 12.8 (5/36) 5.6 (2/36) 0.626
Macrolides Tylosin 7.5 (3/40) 6.9 (4/58) 6.7 (4/60) 7.0 (3/43) 9.8 (4/41) 5.6 (2/36) 1
Aminoglycoside-
lincosamides
Lincospectinc 22.5 (9/40) 48.3 (28/58) 26.7 (16/60) 39.5 (17/43) 58.5 (24/41) 38.9 (14/36) 0.066
Lincosamides Clindamycin 22.5 (9/40) 25.9 (15/58) 26.7 (16/60) 32.6 (14/43) 58.5 (24/41) 27.8 (10/36) 0.022
Others Amoxicillin/clavulanic acid 22.5 (9/40) 6.9 (4/58) 5.0 (3/60) 2.3 (1/43) 17.1 (7/41) 5.6 (2/36) 0.225
aP-value of CAT Test = P-value of Cochran-Armitage trend test
bCo-trimoxazole = Trimethoprim-sulphamethoxazole
cLincospectin = Espectinomycine-lincomycine
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pseudintermedius. For example, between 2007 and 2012
the proportion of AMR S. aureus ranged from 87.5 to
100% compared to 68% to 84% among S. pseudinterme-
dius isolates.
MDR S. aureus were more common than MDR S.
pseudintermedius during the period 2007 to 2012 with
the exception of 2011. In 2011, 39% of S. pseudinterme-
dius were MDR compared to 33% of S. aureus isolates.
While, between 2007–2010 and 2012 the proportion of
MDR S. aureus ranged from 53 to 30% compared to
16% to 39% among S. pseudintermedius isolates. No
significant temporal trends were observed in the propor-
tions of MDR S. aureus (p = 0.8212) or MDR S. pseudin-
termedius (p = 0.0932) (Fig. 5).
Predictors of AMR or MDR Staphylococcus spp.
None of the variables investigated in this study had
significant association with the log odds of either AMR
or MDR.
Discussion
Antimicrobial resistance in veterinary medicine and
especially in companion animals is of increasing public
health concern [2, 19]. This problem is exacerbated by
the fact that the relationship between companion
animals and their owners have been implicated in the
cross-transmission and spread of antimicrobial resistant
organisms [20–22]. Since South Africa lacks continuous
assessment and reporting of veterinary related staphylo-
coccal infections and antimicrobial resistance, the results
of this study contribute significantly to improving our
understanding of the trends in antimicrobial resistance
among S. aureus and S. pseudintermedius clinical cases
of dogs.
Antimicrobial resistance patterns
In the present study, we observed high proportions of S.
aureus and S. pseudintermedius isolates resistant to
β-lactam antibiotics (ampicillin and penicillin). This is
consistent with previous studies that have reported
Fig. 3 Antimicrobial agents showing significant temporal trends in resistance based on the Cochran-Armitage trend tests among the S.
pseudintermedius isolates from canine samples tested at the University of Pretoria bacteriology laboratory, 2007–2012
Fig. 4 Proportions of S. aureus and S. pseudintermedius isolates resistant to at least one antibiotic from samples tested at the University of Pretoria
bacteriology laboratory, 2007–2012
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significantly higher levels of resistance of Staphylococcus
species to β-lactam antibiotics compared to other classes
of antimicrobials [23, 24]. This may be associated with
the expression of intrinsic low-affinity to penicillin-
binding proteins (PBPs) among Staphylococcus species
[25] or the excessive use of β-lactam antibiotics in the
treatment of S. aureus and S. pseudintermedius infec-
tions [3]. High levels of resistance to β-lactam antibiotics
observed in this study will undoubtedly affect treatment
and management of Staphylococcus spp. infections.
A significantly higher proportion of S. aureus than S.
pseudintermedius isolates exhibited resistance to lincosa-
mides (lincospectin and clindamycin). The reasons for
this difference are unclear but these findings are consist-
ent with reports of high levels of lincosamide resistance
among S. aureus and S. pseudintermedius in the United
States [26]. These findings suggest that lincosamides
should not be used as alternative drugs in the treatment
of staphylococcal infections in this population of dogs
[27]. Of concern is the fact that lincosamides, such as
clindamycin, have been generally known to be effective
against Methicillin-Resistant Staphylococcus aureus
(MRSA) and multidrug resistant staphylococci [28].
However, we observed that up to 59% of the S. pseudin-
termedius positive samples were resistant to lincosa-
mides. This seems to suggest that lincosamides should
not be considered for treatment of S. pseudintermedius
infections in this population of dogs without first
performing antibiograms.
Temporal patterns
Over the study period, S. aureus resistance to doxycyc-
line, kanamycin, amoxicillin/clavulanic acid and tylosin
decreased significantly while resistance to fluoroquino-
lones among S. aureus and S. pseudintermedius positive
samples significantly increased. A study conducted over
a 14-year period in Canada by Prescott et al. [3] reported
no significant temporal changes in S. aureus resistance
to fluoroquinolones. Similar to findings by Pellerin et al.
[5] in France among S. pseudintermedius isolates tested
between 1987 and 1996, we observed an increasing trend
in resistance to trimethoprim-sulphamethoxazole among
S. pseudintermedius. The observed decrease or increase
in antimicrobial resistance in the current study may be due
to changes in usage patterns as suggested by other authors
[3, 26]. Moreover, a causal link between trimethoprim-
sulphamethoxazole usage and trimethoprim-sulphametho
xazole resistance in patients with urinary tract infections
(UTI) has been established [29]. It has also been suggested
that rapid introduction of fluoroquinolone and
Trimethoprim-sulphamethoxazole drugs into companion
veterinary medicine practice may also be a contributing fac-
tor to increased prevalence of resistance [30]. The authors
of the present study think that this might be the case in this
study. However, further investigations of the antimicrobial
prescription practices among clinicians at the veterinary
hospital is needed to better understand this.
Hauschild and Wójcik [4] reported 88% resistance to
at least one antimicrobial drug among canine Staphylo-
coccus isolates in Poland, whereas, Lilenbaum et al. [31]
in Canada, reported 90.9% resistance among Staphylo-
coccus spp. In our study, 80.5% of the Staphylococcus
spp. isolates exhibited resistance to at least one anti-
microbial drug. With regards to multi-drug resistance,
the percentage MDR isolates in the current study was
higher (28.7%) than the 24.5% reported by Gandolfi-
Decristophoris et al. [32] in Switzerland and lower
than the 34% as reported by Schmidt et al. [33] in
the UK. The reasons for the high MDR among
Staphylococcus spp. isolates in this study is unclear.
However, we hypothesise that this may be an early
indication of changes in the usage patterns among
veterinarians caring for animals whose samples were
included in the study. In view of this, more research
needs to be done to provide a much clearer picture
of the situation.
Fig. 5 Proportions of multidrug resistant S. aureus and S. pseudintermedius isolates from samples tested at the University of Pretoria veterinary
bacteriology laboratory, 2007–2012
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Distribution and predictors of AMR or MDR
Almost 100% of the S. aureus positive samples were
resistant to at least one antimicrobial agent compared to
only 77% of S. pseudintermedius positive samples. Al-
though resistance to at least one antimicrobial agent was
lower among S. pseudintermedius, it was much higher
than 5.2% reported as by Vanni et al. [34] in Italy and 2–
40% as reported by Blunt et al. [35] in South Africa. Our
findings are consistent with reports of higher levels of
MDR among S. aureus (ranging from 51% to 67%)
compared to S. pseudintermedius (ranging from 5% to
14%) in the UK [36] and Canada [6]. On the contrary,
Jung-Ho Youn et al. [37] reported no MDR in S. aureus
compared to 10.4% MDR among S. pseudintermedius in
Zambia. The results of this study suggest that MDR is
more common in S. aureus isolates than S. pseudinter-
medius from dogs presented at the veterinary academic
hospital in South Africa.
Study limitations
Hoekstra and Paulton [6] reported that the site of isola-
tion is a risk factor of resistance. Unfortunately, we
could not assess this in the current study due to the
large number of categories (site types) and the small
sample sizes associated with each category (site type).
Some of the categories in some of the sub-analyses per-
formed had low sample sizes and high variances hence
lower precision. Previous exposure to antimicrobial
agents has been associated with increased risk of devel-
opment of antimicrobial resistance [20]. Unfortunately,
due to the retrospective nature of the current study, the
history of antibiotic use was not available. Therefore, we
could not investigate the association between previous
antibiotic use and antimicrobial resistance patterns. Fur-
thermore, the study focused on canine clinical cases that
were submitted to the bacteriology laboratory for diag-
nosis. Often such cases would include animals that have
not responded well to previous treatments. Therefore, it
is possible that a large population of dogs that
responded to empirical treatments were not included in
this study. Some sub-analyses were not possible due to
relatively low sample sizes associated with some categor-
ies of some variables such as specimen type. Addition-
ally, the time when culture and sensitivity test was done
in relation to the time after hospital admission of the
dogs was not available making it impossible to identify
nosocomial from community acquired infections. More-
over, the geographic area covered by the study was lim-
ited to Gauteng Province which is not representative of
South Africa as a whole nor is it representative of other
veterinary hospitals in South Africa. These limitations,
notwithstanding, the findings from this study provide
useful information to guide future studies to better
understand antimicrobial resistance in dogs.
Conclusion
Antibiotic resistance among Staphylococcus spp. from
dogs presented to the veterinary academic hospital was
high and continued to increase for enrofloxacin,
trimethoprim-sulphamethoxazole, clindamycin and orbi-
floxacin during the 7-year study period. Of concern are
the increasing levels of resistance to fluoroquinolones
and sulphonamides among S. pseudintermedius. This
calls for urgent action to address the problem. The
actions may include development of antimicrobial
stewardship program for veterinary and para-veterinary
personnel to be offered by the university as part of con-
tinuing education. Furthermore, training of veterinary
students should have a strong emphasis on antimicrobial
stewardship. Lastly, the need for Staphylococcus species
characterization and request for antibiogram as part of
the protocol for diagnosis and treatment of Staphylococ-
cus spp. infections should be emphasized and
encouraged.
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